Senior insider sale
SVP Chief Financial Officer at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$103.5K
4.19K shares
What this filing means
VAIRAVAN LATHA plans to sell 4.19K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $103.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001628280-26-029941
Officer· SVP Chief Financial Officer
Since Feb 2026
4.19K
Shares to sell
$103.5K
Approx. market value
1.34K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
NA
5/1/2026
1.34KTotal acquired1.34K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2026 | Restricted Stock Vesting NA | 1.34K | — |
| Total | 1.34K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.85K
Market value
$71.8K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.34K
Market value
$31.7K
5/4/2026
Total
Units
4.19K
Value
$103.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 2.85K | $71.8K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 1.34K | $31.7K | NASDAQ | Planned |
| Total | 4.19K | $103.5K | ||